Three in Four FDA Authorizations of AI Medical Devices Were in Radiology — 2026 Update
OVERVIEWA study led by GigHz founder finds that approximately 75% of FDA authorizations for AI medical devices through 2026 were concentrated in radiology and medical imaging specialties. This concentration reflects radiology's data richness, clear performance metrics, and regulatory clarity around imaging AI. However, the dominance of imaging AI raises concerns about underinvestment in AI applications for other clinical domains with greater unmet needs, such as primary care triage, chronic disease management, and behavioral health screening. ---
Subscribe to read full wiki analysis
Full wiki content — including source provenance, contradiction tracking, related pages, and analyst notes — is available to Subscriber members.
View Plans & SubscribeNew users get a 7-day trial — no credit card required.